Results 211 to 220 of about 99,958 (297)
Platelet-rich plasma for immature post-traumatic scars and early keloids: A scoping review. [PDF]
Blandón V +5 more
europepmc +1 more source
Abstract Purpose The present study aimed to compare the efficacy and safety of a combined injection of stromal vascular fraction (SVF) and platelet rich plasma (PRP) versus a high molecular weight (HMW) hyaluronic acid (HA) injection in patients with knee osteoarthritis (KOA).
Trifon Totlis +6 more
wiley +1 more source
Comparative Evaluation of Buffy Coat-Derived and Apheresis Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Laboratory and Clinical Insights. [PDF]
Huang C +7 more
europepmc +1 more source
Abstract Purpose To evaluate the safety and efficacy of intra‐articular autologous transplantation of adipose‐derived connective tissue micrografts rich in stromal vascular fraction (CTM‐SVF), obtained using an enzyme‐free system (Hy‐Tissue® SVF) for knee osteoarthritis (OA). Methods Thirty patients (mean age of 53.3 ± 6.4 years) with Kellgren–Lawrence
Laura Mangiavini +11 more
wiley +1 more source
Machine learning predicts clinical response to platelet-rich plasma therapy in knee osteoarthritis. [PDF]
Zhang H, Yang X, Geng T, Wang R, Li G.
europepmc +1 more source
Abstract Purpose To evaluate the failure rates of all‐inside meniscal repair based on tear morphology in stable knees (i.e., without concomitant anterior cruciate ligament reconstruction [ACLR]) and to assess the influence of failure. Methods This retrospective cohort study included 1008 patients who underwent arthroscopic all‐inside meniscal repair ...
Christoffer von Essen +3 more
wiley +1 more source
Efficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial. [PDF]
Ali RE +4 more
europepmc +1 more source
Abstract Purpose The aim was to compare the safety profiles of corticosteroids (CS), hyaluronic acid (HA), blood‐derived products based on platelet concentrates (for simplicity indicated as PRP ‐ platelet‐rich plasma ‐ being PRP the most common product), and cell‐based therapies (namely products exploiting the therapeutic function of mesenchymal ...
Alessandro Bensa +8 more
wiley +1 more source

